HilleVax Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	142.71	218.31	281.03	124.57	0.46
Short-Term Investments	131.67	86.81	0	0	0
Cash & Cash Equivalents	274.37	305.11	281.03	124.57	0.46
Cash Growth	4.65%	8.57%	125.61%	27157.33%	-
Other Current Assets	6.72	5.56	9.58	0.14	0.05
Total Current Assets	281.1	310.68	290.61	124.71	0.51
Property, Plant & Equipment	31.42	32.1	24.95	0.23	0
Other Long-Term Assets	1.65	1.66	1.65	2.22	0
Total Long-Term Assets	33.08	33.76	26.6	2.45	0
Total Assets	314.18	344.43	317.21	127.16	0.51
Accounts Payable	2.98	7.46	4.74	1.02	0.13
Current Debt	3.49	3.12	0.04	158.31	3.02
Other Current Liabilities	19.28	18.69	8.27	68.43	0.12
Total Current Liabilities	25.75	29.27	13.05	227.76	3.28
Long-Term Debt	47.82	48.08	36.36	0.15	0
Other Long-Term Liabilities	1.7	1.57	0.58	0	0
Total Long-Term Liabilities	49.52	49.64	36.94	0.15	0
Total Liabilities	75.27	78.91	49.98	227.92	3.28
Total Debt	51.31	51.19	36.4	158.46	3.02
Debt Growth	35.31%	40.65%	-77.03%	5140.11%	-
Retained Earnings	-435.39	-388.56	-264.99	-105.18	-2.78
Comprehensive Income	-0.95	-0.91	-0.28	0	0
Shareholders' Equity	238.91	265.53	267.23	-100.76	-2.77
Net Cash / Debt	223.07	253.92	244.63	-33.9	-2.57
Net Cash / Debt Growth	-0.53%	3.80%	-	-	-
Net Cash Per Share	4.60	6.25	9.01	-6.03	-0.59
Working Capital	255.35	281.41	277.57	-103.06	-2.77
Book Value Per Share	4.93	6.54	9.84	-17.93	-0.64

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).